Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Clinical trial NCT00363311 · COMPLETED

Trial details

NCT number: NCT00363311
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neoplasms, Prostate

Start date: 2006-07-01
Primary completion: 2010-03-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.